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Tumoral pseudoangiomatous stromal hyperplasia (PASH) is rare and presents more often as a clinically
apparent, well-circumscribed, solid mass. It may clinically and radiologically mimic fibroadenoma or
Phyllodes tumor. In this article, our objective was to describe the clinical presentations, ultrasound
and histopathological appearances of tumoral PASH in three patients. Among the three PASH tumors,
all except one were palpable breast masses; and the non-palpable mass was detected on ultrasound.
All patients underwent core biopsy followed by wide local excision of the mass which were histopatho-
logically proven to be PASH.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Pseudoangiomatous stromal hyperplasia (PASH) is a benign
mesenchymal breast tumor. It is characterized histopathologically
by proliferating stromal myofibroblasts lining slit-like empty
spaces [1]. Tumoral or nodular form of PASH is rare and presents
as a clinically apparent, well-circumscribed, solid mass. It clinically
mimics fibroadenoma or benign Phyllodes tumor, and histologi-
cally it is similar to low grade angiosarcoma. It is commonly seen
incidentally as a focal microscopic finding or associated with
gynecomastia, fibrocystic changes, fibroadenoma, and Phyllodes
tumor [2]. In this article, our objective was to describe the clinical
presentations, imaging and histopathological appearances of
tumoral PASH in three female patients. On ultrasonography
(USG), tumoral PASH usually appears as an oval or round, well-
circumscribed, homogeneously hypoechoic mass, parallel to the
chest wall; less commonly it may have complex echogenicity,irregular shape or ill-defined margins. Histopathology is essential
for confirming the diagnosis. The treatment is wide local excision.
Recurrences have been reported, hence follow-up evaluation is
indicated. Although rare, concomitant breast carcinoma has been
reported with PASH either in the same breast or contralateral
breast [3–5].2. Clinical presentation, imaging findings & histopathology
2.1. Case 1
A 35 year-old female patient came with lumps in both breasts
of 3 months duration. On palpation, the right breast had a firm,
mobile lump measuring 3  3 cm in the upper inner quadrant.
The left breast had a soft, mobile mass measuring approximately
5  3 cm deep to the nipple-areolar complex. There was no axillary
lymphadenopathy. USG of the right breast showed an irregular,
well-defined, predominantly hypoechoic mass measuring
3  2.5 cm in circle 1, 11 O’clock position, with tiny, linear, ane-
choic clefts within (Fig. 1a). Posterior enhancement and minimal
internal vascularity were seen. The mass was soft on elastography
with strain ratio of 0.67. A diagnosis of cellular fibroadenoma or
Phyllodes tumor (U-BI-RADS 3) was suggested. Left breast had an
oval, well-defined, mixed echogenic lesion measuring
6.3  3.2 cm in circle 1, subareolar region, with no obvious internal
vascularity or posterior enhancement (Fig. 1b). Elastography strain
Fig. 1a. Case 1. Right breast USG showing well-defined, hypoechoic mass.
Fig. 1b. Left breast USG showing oval, well-defined, mixed echogenic lesion.
Fig. 1c. H&E stained image of right breast mass showing fibroadenoma; stromal
proliferation compressing the ducts (arrows) (original magnification 40).
Fig. 1d. H&E of left breast mass showing PASH with empty spaces (green arrow)
lined by spindle cells (blue arrow), dense stroma (⁄); ducts (arrowhead) (100).
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RADS 3).
Ultrasound-guided core biopsy of the right breast mass was
done and histologically showed features of fibroadenoma. Ultra-
sound–guided FNAC of the left breast mass showed clusters of
spindle shaped cells in a background of bare nuclei and few atyp-
ical cells. Surgical excision of bilateral breast masses was per-
formed for further detailed examination. On gross evaluation, the
right breast mass measured 7  4  2.5 cm, 45 g, with soft, gray-
yellow external surface and firm, gray-white cut-surface. On
microscopy, uniformly cellular stromal proliferation compressing
the ducts was seen, diagnosed as fibroadenoma (Fig. 1c). The left
breast mass appeared globular, gray-white external surface, mea-
sured 6  5  5 cm, 120 g, with gray-white, soft to firm cut surface
and few slit-like spaces seen within. Microscopy showed prolifera-
tion of stromal elements (fibroblasts and myofibroblasts) admixed
with clusters of ductal cells and anastomosing network of slit-like
empty spaces; with no necrosis or atypia (Fig. 1d). These features
confirmed the diagnosis as PASH.
Three years ago, she had similar complaints of lumps in both
breasts with non-cyclical mastalgia. She had regular menstrual
cycles and a normal delivery. At that time, a mobile mass measur-
ing 2.5  2 cm was present in 12 O’ clock position of right breast;
and a mass measuring 4  4 cm was found in the subareolar region
of left breast. Ultrasound had revealed well-circumscribed, homo-
geneously hypoechoic lesions in bilateral breasts, favoring
fibroadenoma. Bilateral breast masses were excised and
histopathologically both were confirmed as fibroadenoma.Please cite this article in press as: Rafeek N et al. . Egypt J Radiol Nucl Med (22.2. Case 2
A 54 year-old nulliparous lady came with a left breast lump
since 2 months associated with pain and difficulty in lifting the left
arm. On examination, the mass was firm to hard measuring
8  5 cm occupying the upper quadrants of the left breast; with
no nipple retraction, dilated veins, scars or palpable axillary lymph
nodes. Ultrasound revealed an irregular, well-defined, fairly large
mass measuring 9  5  3.5 cm in the upper half (11–2 O’clock
position) of left breast. The mass was heterogeneous and showed
a relatively round, hypoechoic component in its medial aspect
and varied echogenicity in the remaining area (Figs. 2a and 2b).
Central and peripheral vascularity was present. Mixed posterior
features with predominant enhancement were seen. The mass
was assigned into U-BI-RADS 4C category. Right breast was normal.
Multiple core biopsies were taken under ultrasound guidance
from the entire mass as it was large in size. Histopathology
revealed predominantly fibrocollagenous stroma with spindle
shaped cells and few ductal elements- these features raised the
possibility of PASH. Interestingly, on surgical excision, two distinct
masses were found closely adjacent to each other. On gross exam-
ination, the larger mass measured 9  5  2.5 cm, weighing 92.5 g;
had a gray cut-surface and slit-like, cystic spaces within. The smal-
ler mass measured 3.5  3  3 cm, with gray-white cut-surface
and a small hemorrhagic area within. Microscopy of the smaller
mass (3.5 cm) showed numerous spindle-shaped stromal myofi-016), http://dx.doi.org/10.1016/j.ejrnm.2016.10.008
Fig. 2a. Case 2. USG showing irregular, heterogeneous mass with round, hypoe-
choic component (arrows).
Fig. 2b. Color Doppler showing increased vascularity.
N. Rafeek et al. / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxx 3broblasts lining empty interconnecting spaces in a background of
dense stroma, with no necrosis or atypia. These features were sug-
gestive of PASH (Fig. 2c) The larger mass showed stromal prolifer-
ation with increased and heterogeneous cellularity, epithelium-Fig. 2c. H&E of smaller mass showing PASH with spindle cells (blue arrow) lining
empty spaces (green arrow) (200).
Please cite this article in press as: Rafeek N et al. . Egypt J Radiol Nucl Med (2lined clefts, low mitotic index (1/10 high power field), and a leaf-
like contour. These features were diagnostic of benign Phyllodes
tumor (Fig. 2d).
Four years ago, she had a firm to hard, mobile left breast mass
measuring 8  7 cm that developed over a month with pain. Ultra-
sound had revealed an oval, well-circumscribed, homogeneously
hypoechoic lesion which was a fibroadenoma on tru-cut biopsy.
The mass was excised and histopathologically confirmed as
fibroadenoma.2.3. Case 3
A 53 year-old female patient presented with a lump in the left
breast since 6 months, with pain since 3 weeks and bloody nipple
discharge for 1 week. On clinical examination, the left breast had
a firm palpable mass measuring 6  5 cm in the upper inner quad-
rant with irregular borders. There was no palpable axillary lymph
node. Breast symmetry was maintained. The right breast was clin-
ically normal with no palpable lump.
On ultrasound, interestingly, the right breast had an irregular,
well-defined, mixed echogenic-predominantly hypoechoic lesion
measuring 1.7  1.7 cm in circle 1, at 11 O’clock position with
mixed posterior acoustic features. Its elastography strain ratio
was 6.7 with no significant vascularity (Figs. 3a and 3b). Few small,
round, right axillary lymph nodes without fatty hilum were
detected. Considering the irregular shape, high elastography strain
ratio and round axillary lymph nodes, the mass was assigned U-BI-
RADS 4C. Ultrasound of the left breast showed an irregular, ill-
defined, multilobulated, complex echogenic lesion measuring
5  2.7 cm in the subareolar region, with peripheral vascularity
and posterior acoustic shadowing. Microcalcifications were seen
within the mass. Elastography strain ratio was 2.2 (Figs. 3c and
3d). Few enlarged, left axillary lymph nodes with non-uniformly
thickened cortex were also present. The mass was assigned BI-
RADS 5. Ultrasound- guided core biopsy of this mass revealed Not-
tingham histological grade I invasive ductal carcinoma (IDC).
As the right breast mass was small and not palpable,
ultrasound-guided needle-wire localization was performed prior
to surgery (Fig. 4a). Wide excision was done and specimen X-ray
mammogram confirmed the wire in the mass (Figs. 4b and 4c).
On gross evaluation, it measured 3.5  2  1.5 cm with gray-
white, homogeneous cut-surface. Histopathology of this right
breast mass showed PASH (Fig. 4d). Left side modified radical mas-
tectomy was done and specimen was histopathologically proven to
be IDC, with margins free of tumor.Fig. 2d. H&E of larger mass showing benign Phyllodes tumor with stromal
proliferation and leaf-like contour (40).
016), http://dx.doi.org/10.1016/j.ejrnm.2016.10.008
Fig. 3a. Case 3. Right breast USG-irregular, mixed echogenic lesion.
Fig. 3c. Left breast USG-irregular, ill-defined, multilobulated, heterogeneous lesion.
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PASH is commonly detected incidentally as a focal, microscopic
finding or in association with gynecomastia, fibrocystic changes,
fibroadenoma and Phyllodes tumor [2]. It can rarely present as a
clinically apparent, circumscribed, solid nodular or mass lesion-
referred to as nodular or tumoral PASH.
PASH occurs mostly in women of reproductive age and pre-
menopausal women on hormone replacement therapy. Hormonal
effects especially of progesterone are thought to influence myofi-
broblastic proliferation [2,5,6]. PASH can occur in adolescent age
[7–9] and in pregnancy when it presents as a rapidly progressing
or large mass. Nevertheless, mass growth can be rapid in any age
and we must be able to distinguish it from other fast-growing
lesions, especially malignancy.
Clinically and radiologically, tumoral PASH closely resembles
fibroadenoma [4,10]. It most commonly presents as a painless, cir-
cumscribed, palpable mass similar to our case 1. Uncommonly,
PASH can be painful and rapidly growing, like in our case 2. Some-
times it may go unnoticed clinically and is first detected on imag-
ing for evaluation of another mass. This was observed in our case 3.
Tumoral or nodular PASH is best detected on ultrasound. The
mass is characterized, as per BI-RADS, on the basis of its shape, cir-Fig. 3b. Right breast mass elastogra
Please cite this article in press as: Rafeek N et al. . Egypt J Radiol Nucl Med (2cumscription, margins, echogenicity, vascularity and posterior
acoustic features. Tumoral PASH is more often a well-
circumscribed, oval or round mass, parallel to the chest wall as
seen in our case 1. Homogeneous hypoechogenicity is the common
echo pattern. Sometimes they have complex echogenicity and an
irregular shape as we observed in our cases 2 and 3. Rarely, some
cases have been reported to have ill-defined margins, in which it
may be indistinguishable from malignancy. Small internal hypoe-
choic/anechoic areas, or vascular channels may be seen within,
which are usually not seen in fibroadenomas [11]. Tumoral PASH
usually show enhanced, and less commonly has isoechoic or atten-
uated posterior echoes. It can occasionally mimic lymphadenopa-
thy when it occurs in the axillary tail of breast [3].
On mammography, according to BI-RADS, findings are
described as circumscribed mass, focal asymmetric density, archi-
tectural distortion or calcifications. The density of the mass can be
hyperdense, isodense, hypodense, or hypodense with hyperdense
areas within. The most common appearance is a circumscribed,
homogeneously hyperdense mass with regular borders. It may also
present as focal asymmetric density [4,12]. Tumoral PASH is a non-
calcified mass, as opposed to fibroadenomas which may show cal-
cifications within. Calcifications are seen in PASH if there is concur-
rent fibrocystic change, atypical ductal hyperplasia and carcinoma
[4]. PASHmay very rarely present with suspicious borders or archi-
tectural distortion [4,10,13].m showing strain ratio of 6.7.
016), http://dx.doi.org/10.1016/j.ejrnm.2016.10.008
Fig. 3d. Left breast mass elastogram showing strain ratio of 2.2.
Fig. 4a. Case 3. Ultrasound-guided needle-wire localization of right breast mass
prior to surgery.
Fig. 4b. Gross specimen of right breast mass.
Fig. 4c. Specimen mammogram with wire in situ.
Fig. 4d. H&E of right breast mass showing features of PASH (100).
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cular/proliferative types. Simple PASH is characterized by a discon-
tinuous layer of flat or spindle-shaped myofibroblasts (without
atypia) lining interconnecting, slit-like, open, empty spaces; no
red blood cells within these spaces. Fascicular/proliferative type
has multiple clusters of proliferating bland spindle cells (without
atypia) surrounding the empty spaces [14]. Very low mitotic index
is observed in PASH and typically has no necrosis [1] or invasive
features [14]. The slit-like empty spaces mimic vascular spaces
within a dense collagenous stroma. Immunohistochemical (IHC)
staining is used to differentiate PASH from low-grade angiosar-
coma. Endothelial markers CD31 and factor VIII are positive in
angiosarcoma and negative in PASH. The spindle cells (myofibrob-
lasts) in PASH show positivity for CD34, desmin, vimentin, actin,
progesterone receptors [6]. Excision biopsy is superior to FNAC
and sometimes even tru-cut biopsy, as it provides the entire mass
with adequate tissue for histopathological analysis [15,16]. This is
particularly important in a large mass as we saw in our case 2. Core
biopsy was suggestive of PASH tumor; excision biopsy revealed a
PASH tumor and an adjacent benign Phyllodes tumor.
If PASH is incidentally detected in an asymptomatic person, it
may be regularly followed up for monitoring its growth or excised.
The treatment for tumoral PASH is wide local excision [2]. Recur-
rence rates after excision are usually low; a range of 15–22% is
reported in the literature [1,14]. In our cases 1 and 2 (who had a
previous mass in the same site as the present PASH tumor that
was excised and histopathologically diagnosed as fibroadenoma),
we re-examined the past histopathology slides for any evidence
of PASH. We found no features of PASH in them. Recurrent PASH
tumors usually behave in a benign manner. Some lesions can
rapidly progress in size. The management for both remains re-
excision. In diffuse or multifocal PASH, mastectomymay be consid-
ered in those with large sized tumors causing significant patient
discomfort [17].
Synchronous breast carcinoma has been described in patients
with tumoral PASH where the malignant mass was located sepa-
rate from the PASH tumor in the same breast or in the contralateral
breast [3–5]. Our case 3 had PASH in the right breast and IDC in the
left breast. Although extremely rare, malignancy can coexist within
the same site of the PASH tumor. Ferreira et al. described such a
case, which had imaging features suspicious of malignancy. On
core biopsy, IDC was present and no evidence of PASH; whereas
on complete excision, the carcinoma was found localized within
the underlying PASH tumor [3]. Hargaden et al. reported that 4%
of the PASH cases they studied had coexistent carcinomas at the
site of PASH [4]. Our case 2, on ultrasound, showed an irregular,
well-defined, large, heterogeneous mass with central and periph-
eral vascularity, minimal posterior enhancement, hence suspected
to be malignant. Core biopsy showed features of PASH. Wide exci-
sion was performed to rule out any coexisting malignancy.
Histopathological examination confirmed that the mass seen on
imaging was not only a PASH tumor but also a closely adjacent
benign Phyllodes tumor.
Imaging plays a crucial role in identifying the suspicious fea-
tures of malignancy. In cases with suspicious imaging features,
core biopsy diagnosis may not be completely reliable and exci-
sional biopsy is indicated to confirm the histopathological diagno-
sis of the entire mass. If no suspicious features are detected and the
imaging findings correlate with histopathological diagnosis at
core-biopsy, excision biopsy may not be necessary. Such cases
are to be evaluated with regular follow-up imaging to monitor
interval growth of the mass. The rate of growth of the mass on
follow-up imaging is reported to vary over 0–71.4% [13]. On
long-term follow-up, no subsequent malignancy was found at the
same site of PASH in a study by Hargaden et al. [4].Please cite this article in press as: Rafeek N et al. . Egypt J Radiol Nucl Med (24. Conclusion
Tumoral PASH is a rare benign mesenchymal tumor which pre-
sents as a well-circumscribed, solid, clinically apparent mass.
Ultrasound and mammography are useful for characterizing the
mass as per BI-RADS classification and determining the location
of deep, clinically non-palpable, small masses using needle-wire
localization for accurate excision. Ultrasound appearances of
tumoral PASH and fibroadenoma are closely similar and often
these cannot be differentiated. Ultrasound-guided core biopsy is
used to confirm the histopathological diagnosis. If core biopsy
diagnosis is not specific or not concordant with the clinical suspi-
cion, excision biopsy is mandatory for confirmation. The treatment
of tumoral PASH is wide local excision. Follow-up evaluation is
strongly recommended in these cases to detect recurrence of PASH
and for early detection of synchronous breast malignancy in the
same or contralateral breast. Imaging is crucial in detecting any
suspicious features of malignancy.
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